SPHK1 and esophageal cancer: Interestingly, in esophageal cancer, the high expression of SPHK1 is associated with poor 5-year OS and increased SPHK1 levels are significantly correlated with LN metastasis; therefore, SPHK1 is a potential biomarker for outcome prediction in clinical practice (22).